Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-857-7 | CAS number: 14024-56-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 28 days
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Deviations:
- no
- GLP compliance:
- no
- Remarks:
- The study was conducted in compliance with Good Laboratory Practice (GLP) of Certification and Accreditation Administration of the People’s Republic of China (CNCA) (revised edition in 2013).
Test material
- Reference substance name:
- Bis(pentane-2,4-dionato-O,O')magnesium
- EC Number:
- 237-857-7
- EC Name:
- Bis(pentane-2,4-dionato-O,O')magnesium
- Cas Number:
- 14024-56-7
- Molecular formula:
- C10H14MgO4
- IUPAC Name:
- magnesium;4-oxopent-2-en-2-olate
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Duration of treatment / exposure:
- 28 days
Doses / concentrationsopen allclose all
- Dose / conc.:
- 600 mg/kg bw (total dose)
- Remarks:
- High dose
- Dose / conc.:
- 300 mg/kg bw (total dose)
- Remarks:
- Middle dose
- Dose / conc.:
- 120 mg/kg bw (total dose)
- Remarks:
- Low dose
- Dose / conc.:
- 30 mg/kg bw (total dose)
- Remarks:
- Low dose
- Dose / conc.:
- 0 mg/kg bw (total dose)
- Remarks:
- Control group
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- There was no death or near death in the whole experiment, no obvious toxic reaction was observed in each dose group of male and female animals. On day 17 and 24 of the administration period, the average body weight of female and male rats in high dose group were lower than the control, showed extremely significant or significant differences. On day 3 of the administration period, weight gain of male and female rats in high dose group were inhibited. On day 17 of the administration period, weight gain of male rats in high dose group were inhibited. On day 3 of the administration period, the average food intake of female and male rats in the high dose group were lower than the control, showed extremely significant or significant differences.
No toxicological changes were found in blood routine, hemagglutination, blood biochemistry and urine routine examination. The blood routine examination showed that reticulocyte (RET) of female and male rats in high dose group were higher than the control at the end of administration period, showed extremely significant or significant differences. There was no statistically significant change in hemagglutination test. The blood biochemistry examination showed that aspartate aminotransferase (AST) of male rats in high dose group were lower than the control at the end of the administration period, showed significant difference. Total bilirubin (TBIL) of male rats in high dose group were higher than the control at the end of the administration period, showed extremely significant difference. Aspartate aminotransferase (AST) and cholinesterase (CHE) of female rats in high dose group were lower than the control at the end of the administration period, showed significant difference. The urine routine examination showed urine ketones (KET) of male rats in high dose group were lower than the control at the end of the administration period, showed significant difference.
The gross anatomical results showed that, one female rat (2109) had large heart and heart yellow-white color change in very low dose group; One female rat (2300) had large uterus in middle dose group, and other animals were not abnormal.
The results of organ weight showed that absolute weight and testis of male rats in high dose group were lower than the control at the end of the administration period, showed extremely significant or significant statistical difference. Liver to body weight ratio, brain to body weight ratio and adrenal gland to body weight ratio of male rats in high dose group were higher than the control at the end of the administration period, showed extremely significant or significant statistical difference. Testis to brain ratio of male rats in high dose group were lower than the control at the end of the administration period, showed significant statistical difference. Kidney to body weight ratio of female rats in high dose group were higher than the control at the end of the administration period, showed significant statistical difference.
Histopathological examination showed that the incidence of splenic vacuolar degeneration and the decrease of splenic red pulp cells in female middle and high dose groups were very significantly (or significantly) higher than those in the control group. It was considered that this test had the effect of inducing splenic vacuolar degeneration and the decrease in the number of splenic red pulp cells in the middle and high dose groups of females under the experimental conditions. There were only two cases of splenic vacuolar degeneration in the female low-dose group, and there was no significant difference. However, since these two lesions were the results of the role of the test chemical, it was considered that under the experimental conditions, the test chemical also had the effect of reducing the number of splenic red pulp in the female low dose group, and no such lesion was found in the spleen of male experimental animals. - Mortality:
- no mortality observed
- Description (incidence):
- There was no death or near death in the whole experiment, no obvious toxic reaction was observed in each dose group of male and female animals.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- On day 17 and 24 of the administration period, the average body weight of female and male rats in high dose group were lower than the control, showed extremely significant or significant differences. On day 3 of the administration period, weight gain of male and female rats in high dose group were inhibited. On day 17 of the administration period, weight gain of male rats in high dose group were inhibited. On day 3 of the administration period, the average food intake of female and male rats in the high dose group were lower than the control, showed extremely significant or significant differences.
- Description (incidence and severity):
- The urine routine examination showed urine ketones (KET) of male rats in high dose group were lower than the control at the end of the administration period, showed significant difference.
- Description (incidence and severity):
- The results of organ weight showed that absolute weight and testis of male rats in high dose group were lower than the control at the end of the administration period, showed extremely significant or significant statistical difference. Liver to body weight ratio, brain to body weight ratio and adrenal gland to body weight ratio of male rats in high dose group were higher than the control at the end of the administration period, showed extremely significant or significant statistical difference. Testis to brain ratio of male rats in high dose group were lower than the control at the end of the administration period, showed significant statistical difference. Kidney to body weight ratio of female rats in high dose group were higher than the control at the end of the administration period, showed significant statistical difference.
- Description (incidence and severity):
- Histopathological examination showed that the incidence of splenic vacuolar degeneration and the decrease of splenic red pulp cells in female middle and high dose groups were very significantly (or significantly) higher than those in the control group. It was considered that this test had the effect of inducing splenic vacuolar degeneration and the decrease in the number of splenic red pulp cells in the middle and high dose groups of females under the experimental conditions. There were only two cases of splenic vacuolar degeneration in the female low-dose group, and there was no significant difference. However, since these two lesions were the results of the role of the test chemical, it was considered that under the experimental conditions, the test chemical also had the effect of reducing the number of splenic red pulp in the female low dose group, and no such lesion was found in the spleen of male experimental animals.
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 30 mg/kg bw/day (nominal)
- Sex:
- female
- Basis for effect level:
- histopathology: non-neoplastic
- Remarks on result:
- other: splenic vacuolar degeneration and the decrease in the number of splenic red pulp cells in the middle and high dose groups of females under the experimental conditions
- Dose descriptor:
- NOAEL
- Effect level:
- 300 mg/kg bw/day (nominal)
- Sex:
- male
- Basis for effect level:
- body weight and weight gain
Target system / organ toxicity
- Critical effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- According to the results of this experiment, it was concluded that repeated oral administration of N56 for 28 days had toxic effects on SD rats at the dose of 600 mg/kg, suspected to have an impact on the spleen of female rats. At the end of the 14d recovery period, no significant delayed toxicity effect was observed. According to the results of average weight change, the NOAEL in male rats was 300 mg/kg ; According to the results of pathological examination, the NOAEL in female rats was 30 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.